TechNavio's analysts forecast the Global Veterinary Vaccines market to grow at a CAGR of 12.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in prevalence of zoonotic diseases in hu...
|
$ 1500
|
|
|
Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline
Summary
GBI Research, the leading business intelligence provider, has released its latest research, “No
|
$ 3500
|
|
|
Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019
Summary
GlobalData, the industry analysis specialist, has released its new report, “Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to
|
$ 3995
|
|
|
Vaccines are one of the most dynamic parts of the pharmaceutical business today but future growth will depend on a considerable amount of potential vaccines in the pipeline.This Kalorama Information report What's Next in Vaccines? examines and...
|
$ 3995
|
|
|
After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release quantity of human vaccine footed up to roughly ...
|
$ 2400
|
|
|
This research on Chinese influenza vaccine market has 155 Tables and Figures and is a professional and in-depth report. Firstly the study describes the background knowledge of Influenza Vaccine, including Concepts, Classification, Manufacturing pr...
|
$ 2200
|
|
|
The government-sponsored Universal Immunization Program procures vaccines at very low prices, predominantly from local manufacturers. There also exists a large private market for vaccines which is dominated by multinational companies. The private ...
|
$ 5700
|
|
|
The report provides an in-depth analysis of six vaccines which include hepatitis A, hepatitis B, polio, rotavirus, Mumps, Measles and Rubella (MMR) and Diphtheria, Tetanus and Pertussis (DTaP). The report also examines the immunization schedules f...
|
$ 3500
|
|
|
This report provides in-depth analysis of biologics recalls issued or reported with the US Food and Drug Administration (FDA) and its constituent agencies. The report analyzes biologics recalls on the basis of the reason for recall, therapy area, ...
|
$ 3500
|
|
|
Report SummaryThe research object of the report is human vaccine apart from animal vaccine. Vaccination is the most economical, effective, safe and convenient way to prevent disease and the investment of vaccination i...
|
$ 3000
|
|
|
Report SummaryThe considerable revenue growth in the vaccine market over the past ten years suggests the amount of vaccine production and the techniques of vaccine production will need to adapt to match a revived indus...
|
$ 2500
|
|
|
Report SummaryGBI Research, the leading business intelligence provider, has released its latest research, Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal...
|
$ 3500
|
|
|
Report SummaryGBI Research, the leading business intelligence provider has released its latest research Seasonal Influenza Vaccine Market in Asia-Pacific Region – Cell Culture Technology-Based Vaccines to Revolutioniz...
|
$ 3500
|
|
|
Report SummaryTechNavio’s analysts forecast the Global Vaccine market to grow at a CAGR of 9.8 percent over the period 2010–2014. One of the key factors contributing to this market growth is the focus on d...
|
$ 1500
|
|
|
Report SummaryGBI Research, the leading business intelligence provider has released its latest research Seasonal Influenza Vaccine Market in Asia-Pacific Region – Increase in Vaccination Coverage Population to ...
|
$ 3500
|
|
|
IntroductionThis report presents an overview of the market environment for vaccine makers in China. It discusses vaccine recommendations and coverage, the regulatory situation, pricing an reimbursement and vaccine distribut...
|
$ 5700
|
|
|
Report SummaryGBI Research, the leading business intelligence provider, has released its latest research, Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to...
|
$ 3500
|
|
|
GlobalData, the industry analysis specialist, has released its new report, “Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global hepatitis b vaccines mar
|
$ 3500
|
|
|
GBI Research, the leading business intelligence provider, has released its latest research, Emerging Cancer Vaccines Market to 2017”...
|
$ 3500
|
|
|
GlobalData, the industry analysis specialist, has released its new report, “”. The repor
|
$ 3500
|
|
|